Canada markets open in 1 hour 15 minutes

Geron Corporation (GERN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
2.29000.0000 (0.00%)
At close: 04:00PM EST
2.3000 +0.01 (+0.44%)
Pre-Market: 08:00AM EST
Full screen
Trade prices are not sourced from all markets
Previous Close2.2900
Bid2.3000 x 21500
Ask2.3700 x 4000
Day's Range2.2450 - 2.3100
52 Week Range0.9900 - 3.0600
Avg. Volume3,519,501
Market Cap873.028M
Beta (5Y Monthly)0.78
PE Ratio (TTM)N/A
EPS (TTM)-0.3590
Earnings DateNov 03, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.33
  • Zacks

    Why Is Axsome (AXSM) Up 18.6% Since Last Earnings Report?

    Axsome (AXSM) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Business Wire

    Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    FOSTER CITY, Calif., November 17, 2022--Geron Corporation (Nasdaq: GERN) today reported that it has granted non-statutory stock options to purchase an aggregate of 566,890 shares of Geron common stock as inducements to newly hired employees in connection with commencement of employment with the Company.

  • Business Wire

    Geron to Participate in Stifel 2022 Healthcare Conference

    FOSTER CITY, Calif., November 07, 2022--Geron Corporation (Nasdaq: GERN), a late-stage biopharmaceutical company focused on the development and commercialization of treatments for hematologic malignancies, today announced that John A. Scarlett, M.D., Geron’s Chairman and Chief Executive Officer, is scheduled to participate in a fireside chat in person at the Stifel 2022 Healthcare Conference in New York City on Tuesday, November 15, 2022 at 10:55 a.m. ET.